Yes I think that achieving a Phase III approval from the FDA is worth trumpeting...particularly when some very knowledgeable people were saying that it would never happen and "you can take that to the bank." I think the share price argument is particularly weak especially from someone who understands that...
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Market Data 
Markets 
AI
